The β‐adrenoceptors mediating relaxation of rat oesophageal muscularis mucosae are predominantly of the β3‐, but also of the β2‐subtype
Open Access
- 1 September 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (1) , 442-446
- https://doi.org/10.1111/j.1476-5381.1993.tb13830.x
Abstract
β‐Adrenoceptor‐mediated relaxation of rat oesophageal smooth muscle was investigated by studying the effects of β1‐ and β2‐selective antagonists on the relaxation induced by (−)‐isoprenaline, the β2‐selective agonists fenoterol and clenbuterol and the β3‐agonist, BRL 37344. The highly β1‐selective antagonist CGP 20712A did not antagonize (−)‐isoprenaline‐ or BRL 37344‐induced relaxations in concentrations up to 10 μm. Only at 100 μm of CGP 20712A were clear rightward shifts of the agonist concentration‐response curves (CRCs) observed, with pA2 values of 4.70 and 4.97 against (−)‐isoprenaline and BRL 37344, respectively. ICI 118,551, a potent and selective β2‐antagonist, at 100 nm caused moderate rightward shifts of the CRCs of (−)‐isoprenaline, fenoterol and clenbuterol; with fenoterol and clenbuterol, this was accompanied by a clear steepening of the curve. Only at the highest concentration (100 μm ICI 118,551) did the shifts to the right further increase substantially. Resulting Schild‐plots were clearly biphasic. BRL 37344‐induced relaxations were only antagonized at 100 μm ICI 118,551, yielding a pA2 value of 5.48. These results clearly demonstrate that the BRL 37344‐induced relaxation of rat oesophageal muscularis mucosae is mediated solely through β3‐adrenoceptors, whereas (−)‐isoprenaline‐, fenoterol‐ and clenbuterol‐induced relaxations were shown to involve both β2‐ and, predominantly, β3‐adrenoceptors.Keywords
This publication has 29 references indexed in Scilit:
- Structural basis for functional diversity of β1-, β2- and β3-adrenergic receptorsBiochemical Pharmacology, 1991
- Discrepancies in Lipolytic Activities Induced by β-Adrenoceptor Agonists in Human and Rat AdipocytesHormone and Metabolic Research, 1990
- Is the adipocyte β-adrenoceptor a prototype for the recently cloned atypical ‘β3-adrenoceptor?’Trends in Pharmacological Sciences, 1990
- Molecular Characterization of the Human β 3 -Adrenergic ReceptorScience, 1989
- Role of phosphoinositide metabolism in functional antagonism of airway smooth muscle contraction by β-adrenoceptor agonistsEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- An investigation of the β-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscleBiochemical Pharmacology, 1988
- CGP 20712 A: a useful tool for quantitating β1- and β2-adrenoceptorsEuropean Journal of Pharmacology, 1986
- Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugsNature, 1984
- How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?Journal of Pharmacy and Pharmacology, 1978
- Differentiation of β-adrenoceptors in right atrium, diaphragm and adipose tissue of the rat, using stereoisomers of propranolol, alprenolol, nifenalol and practololLife Sciences, 1977